Clinical evaluation of Clareon multifocal IO

Not Applicable

• Conditions: Cataract; Ocular disease; D002386

• Registration Number: JPRN-jRCTs032220042
• Lead Sponsor: Bissen Hiroko

Brief Summary

This study was aimed to examine visual functions after binocular implantations of Clareon-material PanOptix IOLs, and compare with outcomes with the use of previous AcrySof-material IOLs. Postoperative binocular visual functions were preferred, and significant difference from the use of the previous IOLs was not found.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-26
• Study Completion: 2023-02-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients who meet all of the following criteria are included in this study:
1) Patients who will undergo bilateral cataract surgery and are eligible for multifocal IOL implantation in both eyes.
2) Patients aged from 40 to 79 years when enrolled.
3) Patients whose preoperative corneal astigmatism of 1.0 D or less.
4) Patients whose postoperative corrected distance visual acuity is expected to be 0.5 or better.

Exclusion Criteria

1) Patients with any ocular disease influencing visual function, except for cataract.
2) Patients with irregular corneal astigmatism.
3) Patients with history of intraocular or corneal surgery
4) Patients with other systemic or ophthalmic diseases considered to be unsuitable by an investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified